EH 2_2015

C.difficile ? OneStep - One Test 4 targets www.gbo.com/diagnostics Greiner Bio-One GmbH | Bad Haller Straße 32 | A-4550 Kremsmünster Phone: (+43) 75 83 67 91-0 | Fax: (+43) 75 83 63 18 | E-mail: office@at.gbo.com OneStep ahead Genspeed® C.diff OneStep - The new molecular way of detecting C. diff • OneStep diagnostic algorithm: 1 Assay - 4 Analysis: GDH, toxin A/B and binary toxin • Simple pre-analytics and inter-lab comparability of results • Detection of predictive marker for recurring C. difficile-colitis • Fast turnaround time - results in under 100 min (total time varies with cycler used) C.diff OneStep visit us at ECCMID Booth N° 218 Source:Shutterstock/Ociacia www.healthcare-in-europe.com 11LABORATORY l diagnostics on standards of different legislations beyond the European Union. ‘The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the World Association of Pathology and Laboratory Medicine (WAsPaLM) are also working towards the creation of job profiles that are standard- ised worldwide and with compara- ble competencies. Not all partners are always weighted equally, which is partly due to sheer size – the American Association of Clinical Chemistry (AACC), for instance, is only one of 85 specialist associations involved, but it has a huge number of members – and partly also for legal reasons.’ The future is not gloomy In no way is the view towards international harmonisation gloomy, according to Prof. Kohse. ‘When it comes to the contents of our activities, there are now hardly any national differences. There are pro- cedures recommended by the inter- national specialist associations and societies for the most important determination methods. The subject of quality assurance is basically han- dled in a very similar way the world over, although subtle differences will continue, due not least to different philosophies (such as target values for reference methods vs. consensus on target values for inter-laboratory test samples). ‘Standards organisations on a national (DIN), European (EN) and international (ISO) level also make significant contributions towards standardisation and harmonisation. They determine important specifica- tions. For instance, one noticeable example is the definition of a uni- fied standard for the competency of medical laboratories, which is implemented via accreditation with ISO-Norm 15189. ‘All of this only works because these days we can communicate in unbelievably fast and efficient ways. Sharing activities in internet presen- tations, along with electronic com- munication, enables international discussions with colleagues.’ Klaus Kohse MD directs the Institute for Laboratory Medicine at the Oldenburg Clinical Centre, Oldenburg University Medical Faculty, Germany Continued from page 9 Keeping up with an ever-evolving science of non-conventional drugs for the treatment of pathogens, he points out. ‘Very popular are also presenta- tions on promising drug candidates in late-stage clinical trials, which will be the subject of oral sessions, poster presentations and a pipeline corner.’ In the pro-con debate on pneu- mococcal conjugate vaccines we expect a vibrant discussion of the advantages and disadvantages of an adult vaccination. Other ECCMID highlights include the lessons learned from the recent Ebola outbreaks, strategies on how to control poliovirus, malaria, multi- drug-resistant tuberculosis and res- piratory viruses, as well as recent news on the eradication of Hepatitis C, he says. Clinical microbiology speakers will highlight developments in cul- ture-based, PCR-based and rapid diagnostics as well as current and future challenges in forensic micro- biology. ‘Participants will also get updates on whole genome sequenc- ing, on the detection and screening for resistant bacteria, the integra- tion of molecular platforms into the laboratory and the use of digital imaging to assess colony morphol- ogy, Prof. Kern points out. Although a quarter of a cen- tury ‘old’, clearly ECCMID remains a sprightly scientific leader and opin- ion shaper. Phone: (+43) 75836791-0 | Fax: (+43) 75836318 | E-mail: office@at.gbo.com

EH 2_2015

Pages Overview